1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow NovalGen Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies NVG-111 - Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma | Phase 1 | Unknown | NovalGen Ltd. | 90 | 2021-05-14 | 2023-07-07 |
Carcinoma, Non-Small-Cell Lung (1) · Leukemia, B-Cell (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Mantle-Cell (1) · Melanoma (1)
United Kingdom (1)